What are the diagnostic criteria for new diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Criteria for New Diabetes

Diabetes is diagnosed when A1C ≥6.5%, fasting plasma glucose ≥126 mg/dL, 2-hour plasma glucose ≥200 mg/dL during a 75-g oral glucose tolerance test, or random plasma glucose ≥200 mg/dL in a patient with classic hyperglycemic symptoms. 1

Four Diagnostic Pathways

Any one of the following establishes the diagnosis:

  • A1C ≥6.5% (48 mmol/mol) performed in a laboratory using an NGSP-certified method standardized to the DCCT assay 1
  • Fasting plasma glucose ≥126 mg/dL (7.0 mmol/L) with fasting defined as no caloric intake for at least 8 hours 1, 2
  • 2-hour plasma glucose ≥200 mg/dL (11.1 mmol/L) during a 75-g oral glucose tolerance test 1, 2
  • Random plasma glucose ≥200 mg/dL (11.1 mmol/L) in a patient with classic symptoms of hyperglycemia (polyuria, polydipsia, unexplained weight loss) 1

Confirmation Requirements

In the absence of unequivocal hyperglycemia or hyperglycemic crisis, results must be confirmed by repeat testing. 1 This is critical because:

  • The same test should be repeated on a different day, or a different test can be performed without delay using a new blood sample 1
  • If two different tests (such as A1C and fasting glucose) are both above diagnostic thresholds, this confirms the diagnosis 1
  • For example, if A1C is 7.0% and a repeat result is 6.8%, the diagnosis is confirmed 1
  • Only patients with classic symptoms of hyperglycemia or hyperglycemic crisis can be diagnosed with a single test result 1

When NOT to Use A1C

Use only plasma glucose criteria in conditions with altered red blood cell turnover: 1

  • Sickle cell disease 1
  • Pregnancy (second and third trimesters) 1
  • Hemodialysis 1
  • Recent blood loss or transfusion 1
  • Erythropoietin therapy 1
  • Glucose-6-phosphate dehydrogenase deficiency 1
  • Hemoglobin variants that interfere with A1C measurement 1

Important Caveats About Test Selection

The three tests do not identify the same individuals as diabetic. 1 This creates practical challenges:

  • A1C has lower sensitivity at the 6.5% cut point compared to 2-hour plasma glucose 1
  • The concordance between fasting glucose and 2-hour glucose is imperfect, as is concordance between A1C and either glucose-based test 1, 2
  • Marked discrepancies between measured A1C and plasma glucose levels should prompt consideration that the A1C assay may not be reliable for that individual 1

Practical Advantages of Each Test

A1C offers greater convenience: 1

  • No fasting required 1, 2
  • Greater preanalytical stability 1, 2
  • Fewer day-to-day perturbations during stress, changes in nutrition, or illness 1

Glucose testing has limitations: 1, 3

  • Fasting glucose has 12-15% day-to-day variability 1, 3
  • Poor preanalytical stability—plasma must be separated immediately or samples kept on ice to prevent glycolysis 1, 3, 2
  • Requires fasting for 8 hours 1, 2

Special Population Considerations

For children and adolescents, the evidence base for A1C diagnostic criteria is limited to adult populations, making it unclear whether the same 6.5% cut point should be used 1

For acute-onset type 1 diabetes in individuals with symptoms of hyperglycemia, plasma glucose should be used instead of A1C 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Criteria for Diabetes and Prediabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Criteria for Prediabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.